Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | MMP1 | P03956 | 4/20 | 0.63 |
| ▸ | MMP2 | P08253 | 4/20 | 0.63 |
| ▸ | MMP9 | P14780 | 4/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.59 |
| ▸ | EGFR | P00533 | 3/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8099023 | 0.87 | KMT2A (0.71) | KMT2AMMP1MMP2MMP9HTT | |
| SCHEMBL8099020 | 0.87 | KMT2A (0.71) | KMT2AMMP1MMP2MMP9HTT | |
| Cinnamoylglycine SCHEMBL1558162 | 0.86 | KMT2A (0.69) | KMT2AMMP1MMP2MMP9HTT | |
| Cinnamoylglycine SCHEMBL1558163 | 0.86 | KMT2A (0.69) | KMT2AMMP1MMP2MMP9HTT | |
| SCHEMBL27449443 | 0.83 | KMT2A (0.65) | KMT2AMMP1MMP2MMP9HTT | |
| SCHEMBL4919237 | 0.83 | KMT2A (0.65) | KMT2AMMP1MMP2MMP9HTT | |
| SCHEMBL4919230 | 0.83 | KMT2A (0.65) | KMT2AMMP1MMP2MMP9HTT | |
| SCHEMBL27449444 | 0.83 | KMT2A (0.65) | KMT2AMMP1MMP2MMP9HTT | |
| SCHEMBL4203722 | 0.82 | HTT (0.45) | KMT2AMMP1MMP2MMP9HTT | |
| SCHEMBL11590847 | 0.82 | KMT2A (0.86) | KMT2AMMP1MMP2MMP9POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250170126-A1 | NOVEL B0AT1 INHIBITOR | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2025-05-29 | — | — | US | disclosed |
| EP-4470533-A1 | NOVEL B0AT1 INHIBITOR | Mitsubishi Tanabe Pharma Corporation (JP) | 2024-12-04 | — | — | EP | disclosed |
| CN-118678949-A | Novel B0AT1 inhibitors | 田边三菱制药株式会社 | 2024-09-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250170126-A1 | NOVEL B0AT1 INHIBITOR | BCAT1, BCAT2, BHMT | KMT2A 327/4885MMP1 3977/4885MMP2 4371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.